RIGL · ISSUER CIK 1034842
RIGEL PHARMACEUTICALS INC
Between Aug 1, 2026 and Oct 29, 2026, 4 RIGEL PHARMACEUTICALS INC insiders reported $0.00 of open-market purchases and $0.00 of sales on SEC Form 4.
↗4 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.
$0.00Insider buying
$0.00Insider selling
$0.00Net open-market
Sep 3, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 3, 202619:02 | Sep 2, 2026 | RIGL | EVP & Chief Financial Officer | M · Exercise | $21.72 | +4,600 | 82,962 | +6% | $100K | ||
| Sep 3, 202619:02 | Sep 1, 2026 | RIGL | EVP & Chief Financial Officer | F · Tax | $47.50 | −928 | 78,362 | -1% | $44K | ||
| Sep 3, 202619:01 | Sep 1, 2026 | RIGL | EVP, Chief Commercial Officer | F · Tax | $47.50 | −874 | 61,622 | -1% | $42K | ||
| Sep 3, 202618:59 | Sep 1, 2026 | RIGL | CEO, President, Director | F · Tax | $47.50 | −2,424 | 273,362 | -1% | $115K | ||
| Sep 3, 202618:59 | Sep 1, 2026 | RIGL | EVP, GC, CCO & Corp Sec | F · Tax | $47.50 | −877 | 50,559 | -2% | $42K |